Coloplast Balance Sheet Health

Financial Health criteria checks 1/6

Coloplast has a total shareholder equity of DKK16.2B and total debt of DKK23.5B, which brings its debt-to-equity ratio to 144.9%. Its total assets and total liabilities are DKK48.1B and DKK31.9B respectively. Coloplast's EBIT is DKK7.0B making its interest coverage ratio 11.6. It has cash and short-term investments of DKK889.0M.

Key information

144.9%

Debt to equity ratio

kr.23.48b

Debt

Interest coverage ratio11.6x
Cashkr.889.00m
Equitykr.16.20b
Total liabilitieskr.31.94b
Total assetskr.48.14b

Recent financial health updates

Recent updates

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Oct 31
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Oct 02
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Sep 16
Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Aug 02
Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Jul 01
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Jun 16
Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Financial Position Analysis

Short Term Liabilities: COLO B's short term assets (DKK10.4B) do not cover its short term liabilities (DKK17.3B).

Long Term Liabilities: COLO B's short term assets (DKK10.4B) do not cover its long term liabilities (DKK14.6B).


Debt to Equity History and Analysis

Debt Level: COLO B's net debt to equity ratio (139.5%) is considered high.

Reducing Debt: COLO B's debt to equity ratio has increased from 41.9% to 144.9% over the past 5 years.

Debt Coverage: COLO B's debt is not well covered by operating cash flow (9.7%).

Interest Coverage: COLO B's interest payments on its debt are well covered by EBIT (11.6x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.